Medpace CEO granted RSUs and options
Troendle August J. reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Troendle August J. reported acquisition or exercise transactions in this Form 4 filing.
Medpace Holdings, Inc. CEO August J. Troendle reported new equity awards and updated his holdings. He received 10,000 restricted stock units and 20,000 employee stock options, each tied to Medpace common stock. Both awards vest in full on the second anniversary of the grant date, subject to his continued employment.
Following these updates, Troendle holds 646,184 common shares directly and 4,733,019 common shares indirectly through Medpace Investors, LLC, where he has sole voting and investment control but disclaims beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
4 txns
Insider
Troendle August J.
Role
CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 20,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 10,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 20,000 contracts (Direct);
Restricted Stock Unit — 10,000 contracts (Direct);
Common Stock — 646,184 shares (Direct);
Common Stock — 4,733,019 shares (Indirect, By Medpace Investors, LLC)
Footnotes (4)
- F1. The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F2. The option vests on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
- F3. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
- F4. The restricted stock units vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Key Figures
Restricted stock units granted: 10,000 units
Stock options granted: 20,000 options
Option exercise price: $410.5400 per share
+5 more
8 metrics
Restricted stock units granted
10,000 units
Grant to CEO on April 24, 2026
Stock options granted
20,000 options
Employee stock options granted April 24, 2026
Option exercise price
$410.5400 per share
Conversion or exercise price for 20,000 options
Option expiration
April 24, 2033
Expiration date for 20,000 employee stock options
Indirect common shares
4,733,019 shares
Held via Medpace Investors, LLC after transactions
Direct common shares
646,184 shares
Directly held by CEO after transactions
RSU underlying shares
10,000 shares
Common shares underlying restricted stock units
Option underlying shares
20,000 shares
Common shares underlying employee stock options
Key Terms
Restricted Stock Unit, Employee Stock Option (Right to Buy), pecuniary interest, beneficially own, +1 more
5 terms
Restricted Stock Unit financial
"security_title": "Restricted Stock Unit""
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Option (Right to Buy) financial
"security_title": "Employee Stock Option (Right to Buy)""
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein"
beneficially own financial
"may be deemed to indirectly beneficially own the securities of the Issuer held by MPI"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
vesting financial
"The option vests on the second anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did MEDP CEO August J. Troendle report on this Form 4?
August J. Troendle reported equity awards rather than open-market trades. He received 10,000 restricted stock units and 20,000 employee stock options, both linked to Medpace common stock, along with updated disclosures of his direct and indirect common share holdings.
What are the details of the new stock option grant to MEDP CEO August J. Troendle?
Troendle received 20,000 employee stock options, each exercisable for one Medpace common share at a conversion or exercise price of $410.5400 per share. The options vest on the second anniversary of the grant date and expire on April 24, 2033.
What are the terms of the restricted stock units granted to Medpace (MEDP) CEO?
The Form 4 shows a grant of 10,000 restricted stock units to Troendle. Each unit represents a contingent right to receive one Medpace common share and vests in full on the second anniversary of the grant date, conditioned on his continued employment.
How are August J. Troendle’s indirect Medpace (MEDP) holdings structured?
His indirect holdings consist of 4,733,019 Medpace common shares held by Medpace Investors, LLC. Troendle is the sole manager and controlling unit holder, with sole voting and investment control, while disclaiming beneficial ownership except to the extent of his pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
